1. Home
  2. LUNG vs GEG Comparison

LUNG vs GEG Comparison

Compare LUNG & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • GEG
  • Stock Information
  • Founded
  • LUNG 1995
  • GEG 1994
  • Country
  • LUNG United States
  • GEG United States
  • Employees
  • LUNG N/A
  • GEG N/A
  • Industry
  • LUNG Industrial Specialties
  • GEG Computer Software: Prepackaged Software
  • Sector
  • LUNG Health Care
  • GEG Technology
  • Exchange
  • LUNG Nasdaq
  • GEG Nasdaq
  • Market Cap
  • LUNG 63.6M
  • GEG 72.4M
  • IPO Year
  • LUNG 2020
  • GEG N/A
  • Fundamental
  • Price
  • LUNG $1.41
  • GEG $2.40
  • Analyst Decision
  • LUNG Buy
  • GEG
  • Analyst Count
  • LUNG 7
  • GEG 0
  • Target Price
  • LUNG $6.81
  • GEG N/A
  • AVG Volume (30 Days)
  • LUNG 7.0M
  • GEG 18.6K
  • Earning Date
  • LUNG 11-12-2025
  • GEG 11-12-2025
  • Dividend Yield
  • LUNG N/A
  • GEG N/A
  • EPS Growth
  • LUNG N/A
  • GEG N/A
  • EPS
  • LUNG N/A
  • GEG 0.12
  • Revenue
  • LUNG $91,664,000.00
  • GEG $23,112,000.00
  • Revenue This Year
  • LUNG $10.41
  • GEG N/A
  • Revenue Next Year
  • LUNG $10.98
  • GEG N/A
  • P/E Ratio
  • LUNG N/A
  • GEG $20.66
  • Revenue Growth
  • LUNG 15.59
  • GEG 24.82
  • 52 Week Low
  • LUNG $1.35
  • GEG $1.75
  • 52 Week High
  • LUNG $9.37
  • GEG $3.51
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.77
  • GEG 49.77
  • Support Level
  • LUNG $1.65
  • GEG $2.30
  • Resistance Level
  • LUNG $2.11
  • GEG $2.50
  • Average True Range (ATR)
  • LUNG 0.17
  • GEG 0.09
  • MACD
  • LUNG -0.05
  • GEG -0.00
  • Stochastic Oscillator
  • LUNG 7.24
  • GEG 50.67

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About GEG Great Elm Group Inc.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.

Share on Social Networks: